QIAGEN N.V.:企業の戦略・SWOT・財務情報

◆英語タイトル:QIAGEN N.V. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C1944
◆発行会社(調査会社):MarketLine
◆発行日:2018年7月
◆ページ数:57
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オランダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

QIAGEN N.V. – Strategy, SWOT and Corporate Finance Report
Summary

QIAGEN N.V. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

QIAGEN N.V. (Qiagen or ‘the company’) is a provider of sample and assay technologies. The company classifies its operations in one business segment. Its products are divided into two main product categories: consumables and related revenues; and automation platforms and instruments. Through these product categories, Qiagen provides sample technologies to extract and purify molecules of interest from biological samples; assay technologies that make the information in these genomic molecules available for analysis and interpretation; bioinformatics solutions; and automated systems used to automate the use of consumables into workflows for a range of laboratory needs. The company has its operations in the Americas, Europe, Middle East, Africa, Asia Pacific and other parts of the world. It is headquartered in Venlo, the Netherlands.

Scope

- Detailed information on QIAGEN N.V. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting QIAGEN N.V. in the form of a SWOT analysis
- An in-depth view of the business model of QIAGEN N.V. including a breakdown and examination of key business segments
- Intelligence on QIAGEN N.V.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about QIAGEN N.V., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of QIAGEN N.V. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess QIAGEN N.V. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on QIAGEN N.V.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
QIAGEN N.V.: Company Overview 9
QIAGEN N.V.: Overview and Key Facts 9
QIAGEN N.V.: Overview 9
QIAGEN N.V.: Key Facts 9
QIAGEN N.V.: Key Employees 11
QIAGEN N.V.: Key Employee Biographies 12
QIAGEN N.V.: Major Products and Services 17
QIAGEN N.V.: Company History 20
QIAGEN N.V.: Management Statement 27
QIAGEN N.V.: Locations and Subsidiaries 29
QIAGEN N.V.: Key Competitors 30
QIAGEN N.V.: Company Analysis 31
QIAGEN N.V.: Business Description 31
QIAGEN N.V.: SWOT Analysis 33
QIAGEN N.V.: SWOT Overview 33
QIAGEN N.V.: Strengths 33
QIAGEN N.V.: Weaknesses 34
QIAGEN N.V.: Opportunities 34
QIAGEN N.V.: Threats 35
QIAGEN N.V.: Corporate Financial Deals Activity 36
QIAGEN N.V.: Financial Deals Overview 36
QIAGEN N.V.: Targets and Partners 38
QIAGEN N.V.: Top Deals 2014 – 2018YTD* 40
QIAGEN N.V.: Advisors 41
QIAGEN N.V.: Top Financial Advisors 41
QIAGEN N.V.: Mergers and Acquisitions 42
QIAGEN N.V.: Corporate Venturing 43
QIAGEN N.V.: Capital Raising 44
QIAGEN N.V.: Partnership 45
QIAGEN N.V.: Recent Developments 46
QIAGEN N.V.: News and Events Summary 46
QIAGEN N.V.: Business Expansion 50
QIAGEN N.V.: Contracts 50
QIAGEN N.V.: Financial Deals 53
QIAGEN N.V.: Financial Performance 53
QIAGEN N.V.: Strategy and Operations 53
Appendix 55
Contact Us 55
Methodology 55
About MarketLine 56

List of Tables
Table 1: QIAGEN N.V.: Key Facts
Table 2: QIAGEN N.V.: Key Employees
Table 3: QIAGEN N.V.: Locations and Subsidiaries
Table 4: QIAGEN N.V.: Key Competitors
Table 5: QIAGEN N.V.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: QIAGEN N.V.: M&A Activity by Geography (TTM*)
Table 7: QIAGEN N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: QIAGEN N.V.: M&A Average Deal Size - Value (US$m)
Table 9: QIAGEN N.V.: Targets and Partners
Table 10: QIAGEN N.V.: Top Deals 2014 - 2018YTD*
Table 11: QIAGEN N.V.: Financial Advisor Ranking by Value (US$m)
Table 12: QIAGEN N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Table 13: QIAGEN N.V.: M&A Activity by Geography (2014 - YTD*2018)
Table 14: QIAGEN N.V.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 15: QIAGEN N.V.: Corporate Venturing by Geography (2014 - YTD*2018)
Table 16: QIAGEN N.V.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 17: QIAGEN N.V.: Capital Raising by Deal Type (2014 - YTD*2018)
Table 18: QIAGEN N.V.: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 19: QIAGEN N.V.: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 20: QIAGEN N.V.: News and Events Summary
Table 21: QIAGEN N.V.: Business Expansion
Table 22: QIAGEN N.V.: Contracts
Table 23: QIAGEN N.V.: Financial Deals
Table 24: QIAGEN N.V.: Financial Performance
Table 25: QIAGEN N.V.: Strategy and Operations

List of Figures
Figure 1: QIAGEN N.V.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: QIAGEN N.V.: M&A Activity by Geography (TTM*)
Figure 3: QIAGEN N.V.: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: QIAGEN N.V.: M&A Average Deal Size - Value (US$m)
Figure 5: QIAGEN N.V.: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: QIAGEN N.V.: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: QIAGEN N.V.: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: QIAGEN N.V.: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: QIAGEN N.V.: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: QIAGEN N.V.: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: QIAGEN N.V.: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: QIAGEN N.V.: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[QIAGEN N.V.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Alarko Holding AS (ALARK):企業の財務・戦略的SWOT分析
    Alarko Holding AS (ALARK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • VeriFone Systems Inc:企業の戦略・SWOT・財務分析
    VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report Summary VeriFone Systems Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Statkraft AS:企業のM&A・事業提携・投資動向
    Statkraft AS - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Statkraft AS Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • ING Bank NV:企業のM&A・事業提携・投資動向
    ING Bank NV - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ING Bank NV Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, ca …
  • Golden State Foods:企業の戦略・SWOT・財務情報
    Golden State Foods - Strategy, SWOT and Corporate Finance Report Summary Golden State Foods - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Nanosonics Ltd (NAN):製薬・医療:M&Aディール及び事業提携情報
    Summary Nanosonics Ltd (Nanosonics) is a medical technology company, which focuses on the development of technologies for infection control. Its product portfolio includes decontamination products and accessories for the prevention of hospital acquired infections (HAI). The company’s trophon EPR is …
  • Globus Medical, Inc. (GMED)-医療機器分野:企業M&A・提携分析
    Summary Globus Medical, Inc. (Globus) is a medical device company which manufactures and markets musculoskeletal implants with focus on the treatment of spine disorders. The company’s product portfolio includes biomaterial products, cervical, deformity, intervertebral fusion, minimally invasive, mot …
  • Riverbed Technology, Inc.:企業の戦略的SWOT分析
    Riverbed Technology, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Australian Postal Corporation:企業の戦略・SWOT・財務分析
    Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report Summary Australian Postal Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • TUV Rheinland AG:企業の戦略的SWOT分析
    TUV Rheinland AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Shields Bag And Printing Company
    Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report Summary Shields Bag And Printing Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Regeneron Pharmaceuticals Inc (REGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Regeneron Pharmaceuticals Inc (Regeneron) is a biopharmaceutical company, which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. The company’s six US FDA-approved medicines and product candidates in development help patients wit …
  • Central Securities Corp (CET):企業の財務・戦略的SWOT分析
    Summary Central Securities Corp (Central Securities) is a financial service provider that provides investment services. The company offers investment management services and stock investment related services. It invests on convertible preferred stocks, bonds, preferred stocks, convertible bonds, war …
  • Valecha Engineering Ltd:企業の戦略・SWOT・財務分析
    Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report Summary Valecha Engineering Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kingsgate Consolidated Limited:企業の戦略・SWOT・財務分析
    Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report Summary Kingsgate Consolidated Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • ReproCELL Inc (4978):製薬・医療:M&Aディール及び事業提携情報
    Summary ReproCELL Inc (ReproCELL) is a biotechnology company that develops and commercializes stem cell technologies. The company offers products in divisions such as research reagents, cultivation materials, and cell and biorepository. Its research reagent products include hES iPSC culture reagents …
  • Vector Group Ltd (VGR):企業の財務・戦略的SWOT分析
    Vector Group Ltd (VGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • DXI Energy Inc (DXI):石油・ガス:M&Aディール及び事業提携情報
    Summary DXI Energy Inc (DXI Energy), formerly Dejour Energy Inc is an upstream oil and gas company. The company undertakes the business of oil and gas exploration, distribution and production. It explores for oil and gas properties in regions of Colorado and British Columbia. DXI Energy operates pro …
  • South Egypt Drug Industries Co:企業の戦略的SWOT分析
    South Egypt Drug Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Medison Pharma Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Medison Pharma Ltd (Medison) is a drug company that develops and manufactures medical products. The company's oncology products include vectibix, myocet, aranesp, symphony and coloprint. Its neurology products are avonex, tysabri, fampyra, provigil, stryker, dysport and firdapse. Medison off …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆